Source: Eur Respir J 2015; 45: 1194-1196
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Tzilas Vasilios, Bouros Demosthenes. Inherent weaknesses of the current ICD coding system regarding idiopathic pulmonary fibrosis. Eur Respir J 2015; 45: 1194-1196

Member's Comments

No comment yet.

Related content which might interest you: Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential Source: Eur Respir Rev, 26 (145) 170071; 10.1183/16000617.0071-2017 Year: 2017 The 2015 guidelines for idiopathic pulmonary fibrosis: an important chapter in the evolution of the management of patients with IPF Source: Eur Respir J 2015; 46: 883-886 Year: 2015 Idiopathic pulmonary fibrosis: current challenges and future perspectives Source: Eur Respir Rev 2013; 22: 103-105 Year: 2013 Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis Year: 2010 The epidemiologic features and the patterns of medical resource use in idiopathic pulmonary fibrosis (IPF) in Korea Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Current and future therapeutic approaches in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: 693-703 Year: 2005 Imaging of idiopathic pulmonary fibrosis based on case presentations: guidelines, pitfalls and prevention of misdiagnosis Source: Virtual Congress 2021 – Imaging grand round Year: 2021 The impact of a network based approach on lung function and symptom duration at diagnosis in idiopathic pulmonary fibrosis Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 STARMAP: an observational study to assess disease-relevant outcomes using home-monitoring devices in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science Source: Eur Respir J 2016; 47:1615-1617 Year: 2016 Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models Source: Eur Respir Rev 2014; 23:231-238 Year: 2014 Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue Source: Eur Respir Rev, 28 (153) 190044; 10.1183/16000617.0044-2019 Year: 2019 Perceptions, experiences and information needs of patients with idiopathic pulmonary fibrosis (IPF): A qualitative study Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Idiopathic pulmonary fibrosis: present understanding and future options Source: Eur Respir Rev 2011; 20: 132-133 Year: 2011 Item generation for a patient reported outcome measure (PRoM) in idiopathic pulmonary fibrosis (IPF): Application of consensus methods Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Possible target genes in idiopathic pulmonary fibrosis Source: Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases Year: 2007 The cardiovascular system in idiopathic pulmonary fibrosis Source: Eur Respir Monogr 2020; 88: 198-211 Year: 2020 Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 48-56 Year: 2012